Showing 2,661 - 2,680 results of 238,842 for search '"5"', query time: 0.35s Refine Results
  1. 2661

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Keneth Iceland, Kasozi

    Published 2021
    Subjects: “…COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola…”
    Get full text
    Article
  2. 2662
  3. 2663
  4. 2664

    Crystal structure of trans-N 1,N 8-bis(2-cyanoethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H42N6 by Rabi Saswata, Dey Lucky, Rahman Ismail M. M., Tiekink Edward R. T., Roy Tapashi Ghosh

    Published 2023-08-01
    “…C22H42N6, triclinic, P 1‾ $\overline{1}$ (no. 2), a = 8.3115(2) Å, b = 8.8263(2) Å, c = 9.7688(2) Å, α = 111.490(2)° $111.490(2){}^{\circ}$ , β = 115.056(2)° $115.056(2){}^{\circ}$ , γ = 93.681(2)° $93.681(2){}^{\circ}$ , V = 583.25(3) Å3, Z = 1, R gt(F) = 0.0465, wR ref(F 2) = 0.1351, T = 294 K.…”
    Get full text
    Article
  5. 2665

    Crystal structure of rac-1,8-bis(2-carbamoylethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H46N6O2 by Paul Pradip, Yasmin Sabina, Rabi Saswata, Rahman Ismail M. M., Tiekink Edward R. T., Roy Tapashi Ghosh

    Published 2023-08-01
    “…C22H46N6O2, triclinic, P1‾ $P\overline{1}$ (no. 2), a = 8.5777(3) Å, b = 9.0205(4) Å, c = 9.9270(3) Å, α = 67.899(3)° $67.899(3){}^{\circ}$ , β = 71.106(3)° $71.106(3){}^{\circ}$ , γ = 63.774(4)° $63.774(4){}^{\circ}$ , V = 626.83(5) Å3, Z = 1, Rgt ${R}_{\mathit{g}\mathit{t}}$ (F) = 0.0400, wRref $w{R}_{\mathit{r}\mathit{e}\mathit{f}}$ (F 2) = 0.1162, T = 298(2) K.…”
    Get full text
    Article
  6. 2666
  7. 2667
  8. 2668

    Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(−) Patients: A Comparative Meta-Analysis by Sivananthan Manoharan, Lee Ying Ying

    Published 2023-01-01
    “…Interestingly, in comparative meta-analysis, EBV(−)/SARS-CoV-2(+) patients had statistically lesser mortality (9.9%) than EBV(+)/SARS-CoV-2(+) patients (23.6%) where RR = 2.31 (95% CI: 1.34–3.99; p=0.003; I2 = 6%). …”
    Get full text
    Article
  9. 2669
  10. 2670
  11. 2671
  12. 2672
  13. 2673
  14. 2674
  15. 2675
  16. 2676
  17. 2677
  18. 2678
  19. 2679
  20. 2680